Health
Individuals Stopping GLP-1 Medications Encounter Abrupt and Intense Hunger
GLP-1 receptor agonists, such as Wegovy and Ozempic, offer significant weight loss and health benefits but stopping them can lead to quick weight regain and rebound hunger. A University of Oxford study reveals that users often return to pre-treatment weights within 1.7 years, with health markers bouncing back even faster. Experts stress the need for comprehensive long-term strategies to manage obesity effectively.
Shotlee··3 min read
